GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
GlycoMimetics (GLYC) - Total assets
Total assets on the balance sheet as of September 2023 : $53.2 M
According to GlycoMimetics 's latest financial reports the company's total assets are $53.2 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
GlycoMimetics - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $51.81 M | -45.08% |
| 2021-12-31 | $94.34 M | -33.95% |
| 2020-12-31 | $0.14 B | -14.97% |
| 2019-12-31 | $0.16 B | -21.82% |
| 2018-12-31 | $0.21 B | 67.08% |
| 2017-12-31 | $0.12 B | 203.35% |
| 2016-12-31 | $42.38 M | -12.53% |
| 2015-12-31 | $48.46 M | -15.37% |
| 2014-12-31 | $57.26 M | 983.83% |
| 2013-12-31 | $5.28 M | -71.32% |
| 2012-12-31 | $18.41 M | -36.28% |
| 2011-12-31 | $28.9 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 314,854.50% | 🇺🇸 USA |
 Pfizer PFE | $226.50 B | 425,648.16% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 262,708.57% | 🇫🇷 France |
 Palatin Technologies PTN | $13.55 M | -74.52% | 🇺🇸 USA |
 bluebird bio
BLUE | $0.61 B | 1,053.38% | 🇺🇸 USA |